• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Cough, Cold and Allergy (Hay Fever) Remedies in the US Product Image

Cough, Cold and Allergy (Hay Fever) Remedies in the US

  • Published: April 2013
  • Region: United States
  • 52 pages
  • Euromonitor International

Cough, cold and allergy (hay fever) remedies faced several challenges in 2012. First, the 2011-2012 flu season was unusually mild. Warmer temperatures, which are less hospitable to flu viruses and also drive people out of confined indoor spaces where infection is more likely, limited cases of both flu and colds in the winter months. Conversely, those same climate factors increased both the intensity and the duration of the spring and autumn allergy seasons. Recalls and greater private label...

Euromonitor International's Cough, Cold and Allergy (Hay Fever) Remedies in USA report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2008-2012, allowing you to identify the sectors driving growth. Forecasts to 2017 illustrate how the market is set to change.

Product coverage: Antihistamines/Allergy Remedies (Systemic), Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies, Cough Remedies, Decongestants, Medicated Confectionery, Paediatric Cough, Cold and Allergy Remedies, Pharyngeal Preparations.

Data coverage: market sizes (historic and forecasts), company shares, brand shares READ MORE >

COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN THE US
Euromonitor International
April 2013

LIST OF CONTENTS AND TABLES

Headlines
Trends
Competitive Landscape
Prospects
Category Data
Table 1 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2007-2012
Table 2 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2007-2012
Table 3 Sales of Decongestants by Category: Value 2007-2012
Table 4 Sales of Decongestants by Category: % Value Growth 2007-2012
Table 5 Sales of Paediatric Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2007-2012
Table 6 Sales of Paediatric Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2007-2012
Table 7 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2008-2012
Table 8 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2009-2012
Table 9 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2012-2017
Table 10 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2012-2017
Bayer Corp in Consumer Health (usa)
Strategic Direction
Key Facts
Summary 1 Bayer Corp: Key Facts
Company Background
Production
Competitive Positioning
Summary 2 Bayer Corp: Competitive Position 2012
Cvs Caremark Corp in Consumer Health (usa)
Strategic Direction
Key Facts
Summary 3 CVS Caremark Corp: Key Facts
Summary 4 CVS Caremark Corp: Operational Indicators (Retail Pharmacy Segment)
Company Background
Production
Competitive Positioning
Summary 5 CVS Caremark Corp: Competitive Position 2012
Mcneil Consumer & Specialty Pharmaceuticals in Consumer Health (usa)
Strategic Direction
Key Facts
Summary 6 McNeil Consumer & Specialty Pharmaceuticals: Key Facts
Summary 7 McNeil Consumer & Specialty Pharmaceuticals: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 8 McNeil Consumer & Specialty Pharmaceuticals: Competitive Position 2012
Pfizer Consumer Healthcare Inc in Consumer Health (usa)
Strategic Direction
Key Facts
Summary 9 Pfizer Consumer Healthcare Inc: Key Facts
Summary 10 Pfizer Consumer Healthcare Inc: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 11 Pfizer Consumer Healthcare Inc: Competitive Position 2012
Walgreen Co in Consumer Health (usa)
Strategic Direction
Key Facts
Summary 12 Walgreen Co: Key Facts
Summary 13 Walgreen Co: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 14 Walgreen Co: Competitive Position 2012
Wal-mart Stores Inc in Consumer Health (usa)
Strategic Direction
Key Facts
Summary 15 Wal-Mart Stores Inc: Key Facts
Summary 16 Wal-Mart Stores Inc: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 17 Wal-Mart Stores Inc: Competitive Position 2012
Executive Summary
Consumer Health Continues Its Upward Climb
Manufacturing Issues Worsen Rather Than Improve
Private Label Producers Capitalise on Branded Product Challenges
Retailers Aim To Play A Broader Role in Consumers' Lives
OTC Rebound Will Drive Higher Growth Over the Forecast Period
Key Trends and Developments
Continuing the Balance Between Industry and Government
Baby Boomers Impact on Vitamins and Dietary Supplements
Growth in Protein Is Bulking Up in Strength
Manufacturing Issues Continue To Plague Consumer Health
Regulatory Prospects Alter Strategic Landscape
Market Indicators
Table 11 Consumer Expenditure on Health Goods and Medical Services 2007-2012
Table 12 Life Expectancy at Birth 2007-2012
Market Data
Table 13 Sales of Consumer Health by Category: Value 2007-2012
Table 14 Sales of Consumer Health by Category: % Value Growth 2007-2012
Table 15 Consumer Health Company Shares 2008-2012
Table 16 Consumer Health Brand Shares 2009-2012
Table 17 Penetration of Private Label by Category 2007-2012
Table 18 Sales of Consumer Health by Distribution Format: % Analysis 2007-2012
Table 19 Sales of Consumer Health by Category and Distribution Format: % Analysis 2012
Table 20 Forecast Sales of Consumer Health by Category: Value 2012-2017
Table 21 Forecast Sales of Consumer Health by Category: % Value Growth 2012-2017
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventative Medicine
Switches
Summary 18 OTC: Switches 2010-2012
Sources
Summary 19 Research Sources

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos